Success Metrics

Clinical Success Rate
92.3%

Based on 24 completed trials

Completion Rate
92%(24/26)
Active Trials
3(9%)
Results Posted
71%(17 trials)
Terminated
2(6%)

Phase Distribution

Ph phase_1
3
9%
Ph phase_4
9
27%
Ph early_phase_1
1
3%
Ph not_applicable
10
30%
Ph phase_3
1
3%
Ph phase_2
7
21%

Phase Distribution

4

Early Stage

7

Mid Stage

10

Late Stage

Phase Distribution31 total trials
Early Phase 1First-in-human
1(3.2%)
Phase 1Safety & dosage
3(9.7%)
Phase 2Efficacy & side effects
7(22.6%)
Phase 3Large-scale testing
1(3.2%)
Phase 4Post-market surveillance
9(29.0%)
N/ANon-phased studies
10(32.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

24 of 28 finished

Non-Completion Rate

14.3%

4 ended early

Currently Active

3

trials recruiting

Total Trials

33

all time

Status Distribution
Active(3)
Completed(24)
Terminated(4)
Other(2)

Detailed Status

Completed24
Recruiting2
Terminated2
Withdrawn2
Active, not recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
33
Active
3
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.2%)
Phase 13 (9.7%)
Phase 27 (22.6%)
Phase 31 (3.2%)
Phase 49 (29.0%)
N/A10 (32.3%)

Trials by Status

active_not_recruiting13%
recruiting26%
terminated26%
suspended13%
completed2473%
unknown13%
withdrawn26%

Recent Activity

3 active trials
Showing 5 of 33
recruitingphase_2

Depressed Mood Improvement Through Nicotine Dosing 3

NCT05746273
active_not_recruitingphase_2

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

NCT05746546
completedphase_4

Tobacco Treatment Comparison for Cancer Care

NCT06218823
recruitingearly_phase_1

Evaluation of the Electronic Cigarette Withdrawal Syndrome

NCT06066996
completedphase_2

Depressed Mood Improvement Through Nicotine Dosing 2

NCT04433767
View all 33 trials

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT05746273Phase 2

Depressed Mood Improvement Through Nicotine Dosing 3

Recruiting
NCT05746546Phase 2

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

Active Not Recruiting
NCT06218823Phase 4

Tobacco Treatment Comparison for Cancer Care

Completed
NCT06066996Early Phase 1

Evaluation of the Electronic Cigarette Withdrawal Syndrome

Recruiting
NCT04433767Phase 2

Depressed Mood Improvement Through Nicotine Dosing 2

Completed
NCT00775749Not Applicable

Transdermal Nicotine in Female Patients at High Risk for Post Operative Nausea and/or Vomiting (PONV)

Withdrawn
NCT04130698Phase 1

Comparing Two Treatments That Both Target Smoking Cessation and Weight Loss at the Same Time.

Withdrawn
NCT01199380Phase 2

Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms

Completed
NCT01351766Phase 3

Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation

Completed
NCT01372254Phase 1

Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment

Completed
NCT00790829Not Applicable

Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery

Terminated
NCT02511236Phase 4

Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention

Completed
NCT03972137Phase 2

Heart Rate Variability Biofeedback for Smoking Cessation

Completed
NCT02869451Not Applicable

Mobile Contingency Management for Marijuana and Tobacco Cessation

Completed
NCT03072511Phase 4

Smoking Cessation Intervention

Terminated
NCT02453659Not Applicable

Women Engaging in Quitting Smoking Together

Completed
NCT00736255Not Applicable

Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study

Completed
NCT01362959Phase 4

Nicotine Replacement Therapy in the Intensive Care Unit

Completed
NCT02873754Not Applicable

Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)

Completed
NCT00664755Phase 2

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

Completed

Drug Details

Intervention Type
DRUG
Total Trials
33